(2024). Using Routinely Collected Electronic Healthcare Record Data to Investigate Fibrotic Multimorbidity in England. Clin Epidemiol, 16, 433-443. http://doi.org/10.2147/clep.s463499
. H. Whittaker
First name
H.
Middle name
R.
Last name
Whittaker
(2024). Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control study. Bmc Pulm Med, 24, 221. http://doi.org/10.1186/s12890-024-03035-4
. (2024). Eligibility of patients with chronic obstructive pulmonary disease for inclusion in randomised control trials investigating triple therapy: a study using routinely collected data. Respir Res, 25, 43. http://doi.org/10.1186/s12931-024-02672-x
. (2023). Temporal Risk of Non-Fatal Cardiovascular Events Post COPD Exacerbation: A Population-based Study. Am J Respir Crit Care Med. http://doi.org/10.1164/rccm.202307-1122OC
. (2022). Inhaled Corticosteroid Withdrawal and Change in Lung Function in Primary Care Chronic Obstructive Pulmonary Disease Patients in England. Ann Am Thorac Soc. http://doi.org/10.1513/AnnalsATS.202111-1238OC
. (2022). Left-sided heart failure burden and mortality in idiopathic pulmonary fibrosis: a population-based study. Bmc Pulm Med, 22, 190. http://doi.org/10.1186/s12890-022-01973-5
. (2019). Inhaled corticosteroids, blood eosinophils, and FEV1 decline in patients with COPD in a large UK primary health care setting. Int J Chron Obstruct Pulmon Dis. http://doi.org/10.2147/copd.s200919
. (2020). Prediction of five-year mortality after COPD diagnosis using primary care records. PLoS One. http://doi.org/10.1371/journal.pone.0236011
. (2020). Characteristics Associated with Accelerated Lung Function Decline in a Primary Care Population with Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. http://doi.org/10.2147/copd.s278981
. (2020). Accelerated FEV(1) decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients. Eur Respir J. http://doi.org/10.1183/13993003.00918-2020
.